Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Clinical trial NCT03393520 · COMPLETED
Trial details
- NCT number
- NCT03393520
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-13
- Primary completion
- 2023-11-17
- Enrollment
- 601
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.